MedTrace Logo

Use of Real-time Continuous Glucose Monitoring System in Patients With Type 1 Diabetes Mellitus

NCT00824148 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-02-27

No results posted yet for this study

Summary

The purpose of this study is to determine whether a real-time continuous glucose monitoring system is able to improve HbA1c in patients suffering from type 1 diabetes compared to conventional finger prick glucose measurements. In addition it will investigate whether number of episodes with serious hypoglycemia is changed in those same patients, and whether quality of life (health status and treatment satisfaction) increases.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DEVICE

Guardian REAL-Time Continuous Glucose Monitoring System

One group will use the glucose monitoring system for 1 month

OTHER

Conventional self-monitoring of plasma glucose

Finger prick blood glucose measurements

Sponsors & Collaborators

  • Norwegian Diabetes Association

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Kristian J Fougner, MD · Departement of Endocrinology St. Olavs Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00824148 on ClinicalTrials.gov